Paper Details
- Home
- Paper Details
Original Abstract of the Article :
The effects of tolazamide (300 mg. daily), a new oral hypoglycemic sulfonylurea, and tolbutamide on the blood glucose, serum insulin, cholesterol and triglyceride levels were compared in 14 subjects with maturity-onset diabetes of varying severity. The mean effects of the two drugs in the pharmacolo...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936014/
データ提供:米国国立医学図書館(NLM)
Comparing the Effects of Tolazamide and Tolbutamide in Diabetic Patients
The management of diabetes mellitus, a chronic metabolic disorder, often involves the use of oral hypoglycemic agents to regulate blood sugar levels. This study compared the effects of tolazamide and tolbutamide, two sulfonylurea drugs, on blood glucose, serum insulin, cholesterol, and triglyceride levels in patients with maturity-onset diabetes. The researchers found that both drugs, when administered at pharmacologically equivalent doses, produced similar effects on blood glucose and serum triglyceride levels, reducing them by 19% and 17%, respectively. However, individual patients exhibited variable responses to each drug, highlighting the importance of personalized treatment approaches.
Individualized Therapy: A Key to Effective Diabetes Management
This study emphasizes the crucial role of individualized therapy in managing diabetes mellitus. While both tolazamide and tolbutamide showed similar effects on average, individual patients may respond differently to each drug. This underscores the importance of careful monitoring and adjusting treatment regimens to meet the specific needs of each patient.
Managing Diabetes: Beyond Blood Sugar Control
This research highlights the importance of addressing multiple metabolic parameters in diabetes management. While blood glucose control is paramount, the study demonstrates the impact of sulfonylurea drugs on lipid levels. This emphasizes the need for a comprehensive approach that considers both glycemic and lipid control in optimizing the health of diabetic patients.
Dr.Camel's Conclusion
Just as a desert traveler needs to find the right path to navigate the shifting sands, diabetes management requires a tailored approach. This study sheds light on the importance of individualized therapy and the need to consider multiple metabolic factors in optimizing treatment outcomes. By working closely with healthcare professionals, individuals with diabetes can navigate the complexities of their condition and strive for a healthier future.
Date :
- Date Completed 1967-04-22
- Date Revised 2018-11-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.